{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:28:45Z","timestamp":1790872125951,"version":"4.1.0"},"reference-count":19,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin resistance, and dyslipidemia as well as increases in C-reactive protein and homocysteine in these different phenotypes with age-matched ovulatory controls of normal weight (n = 85) and others matched for body mass index (BMI) with women with C-PCOS (n = 42). Although BMI affected fasting serum insulin and the Quantitative Insulin-Sensitivity Check Index, these markers of insulin resistance were greatest in C-PCOS (n = 204), followed by OV-PCOS (n = 50) and then IHA (n = 33). Androgen levels were similar in OV-PCOS and IHA but were higher in C-PCOS, whereas gonadotropins were similar in all groups. Lipid abnormalities were highest in C-PCOS and OV-PCOS and were normal in IHA. C-reactive protein was elevated in C-PCOS and OV-PCOS but not IHA. Homocysteine was elevated only in C-PCOS. Overall, the prevalence of obesity (BMI &amp;gt; 30) was 29% in C-PCOS, 8% in OV-PCOS, and 15% in IHA and insulin resistance (Quantitative Insulin-Sensitivity Check Index &amp;lt; 0.33) was 68% in C-PCOS, 36% in OV-PCOS, and 26% in IHA. The prevalence of having at least one elevated cardiovascular risk marker was 45% in C-PCOS 38% in OV-PCOS and was not increased on IHA (6%). These results suggest that among hyperandrogenic women the prevalence of abnormal metabolic and cardiovascular risk parameters is greatest in C-PCOS, followed by OV-PCOS and then women with IHA. Moreover, in that in OV-PCOS and IHA, ages and weights were similar yet the prevalence of metabolic and cardiovascular risk was greater in OV-PCOS, the finding of polycystic ovaries may be a significant modifying factor.<\/jats:p>","DOI":"10.1210\/jc.2004-2279","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T01:24:00Z","timestamp":1115256240000},"page":"2545-2549","source":"Crossref","is-referenced-by-count":213,"title":["Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters"],"prefix":"10.1210","volume":"90","author":[{"given":"E.","family":"Carmina","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine (E.C., R.A.Lon., G.B.R.), University of Palermo, 61-90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine (E.C., R.A.Lon., G.B.R.), University of Palermo, 61-90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. B.","family":"Rini","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine (E.C., R.A.Lon., G.B.R.), University of Palermo, 61-90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Lobo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618430210900_R1","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach","author":"Zawdaki","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;"},{"key":"2020071618430210900_R2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071618430210900_R3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(01)00979-2","article-title":"Polycystic ovaries in women with normal menses.","volume":"111","author":"Carmina","year":"2001","journal-title":"Am J Med"},{"key":"2020071618430210900_R4","first-page":"361","article-title":"Polycystic ovary syndrome:diagnostic criteria","author":"Chang","year":"2002","journal-title":"In: Chang RJ, Heindel JJ, Dunaif A, eds. Polycystic ovary syndrome. New York: Marcel Dekker;"},{"key":"2020071618430210900_R5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071618430210900_R6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome.","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"2020071618430210900_R7","first-page":"939","article-title":"Evaluation of hormonal status","author":"Carmina","year":"2004","journal-title":"In: Strauss III JF, Barbieri RL, eds. Yen and Jaffe\u2019s reproductive endocrinology: physiology, pathophysiology and clinical management. 5th ed. Elsevier-Saunders;"},{"key":"2020071618430210900_R8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions.","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2020071618430210900_R9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Differences in body weight between American and Italian women with the polycystic ovary syndrome: influence of the diet.","volume":"11","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071618430210900_R10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9378(80)90079-4","article-title":"Prolactin modulation of dehydroepiandrosterone sulfate secretion.","volume":"138","author":"Lobo","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"2020071618430210900_R11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(91)90042-P","article-title":"Is 11\u03b2-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone in sulfate.","volume":"66","author":"Stanczyk","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2020071618430210900_R12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative Insulin-Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans.","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618430210900_R13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2020071618430210900_R14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcla.20038","article-title":"Measurement of C-reactive protein: two high sensitivity methods compared.","volume":"18","author":"Dominici","year":"2004","journal-title":"J Clin Lab Anal"},{"key":"2020071618430210900_R15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2000-8468","article-title":"Assay methods for the measurement of total homocysteine in plasma.","volume":"26","author":"Ubbink","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"2020071618430210900_R16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","article-title":"Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.","volume":"82","author":"Carmina","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071618430210900_R17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1530\/eje.0.1390421","article-title":"Prevalence of idiopathic hirsutism.","volume":"139","author":"Carmina","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071618430210900_R18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(03)00735-0","article-title":"Androgen excess is the key element in polycystic ovary syndrome.","volume":"80","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071618430210900_R19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/5\/2545\/10775990\/jcem2545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/5\/2545\/10775990\/jcem2545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:59:30Z","timestamp":1594958370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/90\/5\/2545\/2836648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2004-2279","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}